These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35815081)

  • 1. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity.
    Seyfi S; Alijanpour R; Aryanian Z; Ezoji K; Mahmoudi M
    J Med Life; 2022 May; 15(5):631-634. PubMed ID: 35815081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 infection is a major cause of acute telogen effluvium.
    Sharquie KE; Jabbar RI
    Ir J Med Sci; 2022 Aug; 191(4):1677-1681. PubMed ID: 34467470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID-19 telogen effluvium?
    Koç Yıldırım S; Erbağcı E; Demirel Öğüt N
    J Cosmet Dermatol; 2022 May; 21(5):1809-1815. PubMed ID: 35201647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 induced telogen effluvium.
    Aksoy H; Yıldırım UM; Ergen P; Gürel MS
    Dermatol Ther; 2021 Nov; 34(6):e15175. PubMed ID: 34708909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of telogen effluvium in COVID-19 in western Iran (2020).
    Babaei K; Kavoussi H; Rezaei M; Kavoussi R
    An Bras Dermatol; 2021; 96(6):688-692. PubMed ID: 34593265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red LED light therapy for telogen effluvium in the course of long COVID in patients with and without androgenetic alopecia.
    Gerkowicz A; Bartosińska J; Krakowski P; Karpiński R; Krasowska D; Raczkiewicz D; Kwasny M; Krasowska D
    Ann Agric Environ Med; 2024 Jun; 31(2):239-247. PubMed ID: 38940108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telogen effluvium and COVID-19: a cross-sectional study.
    Aldahish A; Vasudevan R; Salem H; Alqahtani A; AlQasim S; Alqhatani A; Al Shahrani M; Al Mohsen L; Hajla M; Calina D; Sharifi-Rad J
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7823-7830. PubMed ID: 37667959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-COVID Telogen Effluvium.
    Tešanović Perković D; Vukojević M; Bukvić Mokos Z
    Acta Dermatovenerol Croat; 2022 Dec; 30(4):220-226. PubMed ID: 36919388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telogen effluvium associated with COVID-19 infection.
    Olds H; Liu J; Luk K; Lim HW; Ozog D; Rambhatla PV
    Dermatol Ther; 2021 Mar; 34(2):e14761. PubMed ID: 33405302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Hair Loss After COVID-19 Infection in Makkah Region, Saudi Arabia.
    Abdulwahab RA; Aldajani BM; Natto NK; Janabi AM; Alhijaili OI; Faqih NT; Alharbi A
    Cureus; 2022 Sep; 14(9):e29285. PubMed ID: 36277546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation.
    Hussain N; Agarwala P; Iqbal K; Omar HMS; Jangid G; Patel V; Rathore SS; Kumari C; Velasquez-Botero F; López GAB; Vishwakarma Y; Nipu AP; Ahmed NK
    J Med Virol; 2022 Apr; 94(4):1391-1401. PubMed ID: 34931698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential cyclic changes of hair roots revealed by dermoscopy demonstrate a progressive mechanism of diffuse alopecia areata over time.
    Zhang X; Ye Y; Zhu Z; Yang Y; Cao H; McElwee KJ; Ling Y
    Exp Dermatol; 2020 Mar; 29(3):223-230. PubMed ID: 30307062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of QR678 Neo
    Shome D; Kapoor R; Surana M; Vadera S; Shah R
    J Cosmet Dermatol; 2022 Jan; 21(1):16-23. PubMed ID: 34875139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case control study.
    Bedair NI; Abdelaziz AS; Abdelrazik FS; El-Kassas M; AbouHadeed MH
    Arch Dermatol Res; 2024 Jun; 316(6):336. PubMed ID: 38844670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management.
    Starace M; Iorizzo M; Sechi A; Alessandrini AM; Carpanese M; Bruni F; Vara G; Apalla Z; Asz-Sigall D; Barruscotti S; Camacho F; Doche I; Estrada BD; Dhurat R; Gavazzoni MF; Grimalt R; Harries M; Ioannidis D; McMichael A; Melo DF; Oliveira R; Ovcharenko Y; Pirmez R; Ramot Y; Rudnicka L; Shapiro J; Silyuk T; Sinclair R; Tosti A; Vano-Galvan S; Piraccini BM
    JAAD Int; 2021 Dec; 5():11-18. PubMed ID: 34368790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-COVID-19 hair loss: prevalence and associated factors among 5,891 patients.
    Müller-Ramos P; Ianhez M; Silva de Castro CC; Talhari C; Criado PR; Amante Miot H
    Int J Dermatol; 2022 May; 61(5):e162-e164. PubMed ID: 35080250
    [No Abstract]   [Full Text] [Related]  

  • 17. Telogen effluvium caused by COVID-19 in Elmhurst, New York: report of a cohort and review.
    Gruenstein D; O'Mara M; Pa SH; Levitt J; Pa SL; Tom J; Leger M
    Dermatol Online J; 2021 Oct; 27(10):. PubMed ID: 35130383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia.
    Guarnieri G; Bertagna De Marchi L; Marcon A; Panunzi S; Batani V; Caminati M; Furci F; Senna G; Alaibac M; Vianello A
    Ann Med; 2022 Dec; 54(1):869-874. PubMed ID: 35341398
    [No Abstract]   [Full Text] [Related]  

  • 19. Characteristics of hair loss in COVID-19 patients in Thailand.
    Triwongwaranat D; Thanomkitti K; Korviriyakamol T; Saengthong-Aram P; Varothai S; Thuangtong R
    Medicine (Baltimore); 2023 Dec; 102(49):e36539. PubMed ID: 38065902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HrQoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety.
    Russo PM; Fino E; Mancini C; Mazzetti M; Starace M; Piraccini BM
    J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):608-611. PubMed ID: 30394586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.